Page last updated: 2024-10-29

ketamine and Osteogenesis Imperfecta

ketamine has been researched along with Osteogenesis Imperfecta in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Osteogenesis Imperfecta: COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Libman, RH1
Oliverio, RM1

Other Studies

2 other studies available for ketamine and Osteogenesis Imperfecta

ArticleYear
Anesthetic considerations for the patient with osteogenesis imperfecta.
    Clinical orthopaedics and related research, 1981, Issue:159

    Topics: Anesthesia, General; Humans; Ketamine; Osteogenesis Imperfecta

1981
Anesthetic management of intramedullary nailing in osteogenesis imperfecta: report of a case.
    Anesthesia and analgesia, 1973, Volume: 52, Issue:2

    Topics: Anesthesia, General; Child, Preschool; Fracture Fixation, Intramedullary; Humans; Injections, Intram

1973